Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

North America Deep Brain Stimulation Devices Market by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), by Target (Thalamus, Subthalamic Nucleus, Globus Pallidus, Pedunculopontine Nucleus) and by Application (Chronic Pain, Dystonia, Alzheimer's Disease, Depression, Obsessive Compulsive Disorder, Epilepsy, Parkinsons disease, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03837

Pages: NA

Charts: NA

Tables: NA

Deep brain stimulation devices or neurostimulators are used in surgical procedures to treat neurological disorders by sending or blocking electrical signals to the targeted area. It is used to treat various neurological symptoms such as essential tremor, stiffness, and walking disability. Only patients with failed medication history undergo procedure using deep brain stimulation devices.

Factors such as increase in geriatric population, rapid rise in incidences of epilepsy, essential tremors, and increasing cases of Alzheimers & Parkinsons disease drive the growth of the North American deep brain stimulation devices market. However, high cost of devices and risk of infection at the stimulator site restrain the market growth. The new applications of deep brain stimulation devices to treat Alzheimers disease and tinnitus have created opportunities for new as well as existing players in the market.

The North American deep brain stimulation devices market is segmented on the basis of product, target, application, and countries. Based on product, the market is segmented as into single channel and dual channel deep brain stimulator. By target, the market can be categorized into thalamus, subthalamic nucleus, globus pallidus, and pedunculopontine nucleus. Based on application, the market is segmented into chronic pain, dystonia, Alzheimers disease, depression, obsessive compulsive disorder, epilepsy, and Parkinsons disease. By country, this market has been analyzed across the U.S., Canada, and Mexico.

The key players that operate in the market include Medtronic plc, Boston Scientific Corporation, Enteromedics, Cyberonics, St. Jude Medical, Inc., Neuropace, Zynex, Neuronetics, Functional Neuromodulation Ltd., and Neurosigma, Inc.

Key Benefits

  • The study provides an in-depth analysis of the North American deep brain stimulation devices market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the North American deep brain stimulation devices market from 2016 to 2023, which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the North America deep brain stimulation devices market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the North American deep brain stimulation devices.

North America Deep Brain Stimulation Devices Market Key Segments:

By Product

  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator

By Target

  • Thalamus
  • Subthalamic Nucleus
  • Globus Pallidus
  • Pedunculopontine Nucleus

By Application

  • Chronic Pain
  • Dystonia
  • Alzheimer's Disease
  • Depression
  • Obsessive Compulsive Disorder
  • Epilepsy
  • Parkinsons disease
  • Others

By Country

  • U.S.
  • Canada
  • Mexico

 Key Market Segments

  • By Product
    • Single Channel Deep Brain Stimulator
    • Dual Channel Deep Brain Stimulator
  • By Target
    • Thalamus
    • Subthalamic Nucleus
    • Globus Pallidus
    • Pedunculopontine Nucleus
  • By Application
    • Chronic Pain
    • Dystonia
    • Alzheimer's Disease
    • Depression
    • Obsessive Compulsive Disorder
    • Epilepsy
    • Parkinsons disease
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico

 
Key Market Players

  • Neuropace,
  • Zynex,
  • Cyberonics,
  • St. Jude Medical, Inc.,
  • Neuronetics,
  • Medtronic plc,
  • Boston Scientific Corporation,
  • Enteromedics,
  • Neurosigma, Inc.
  • Functional Neuromodulation Ltd.,

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Single Channel Deep Brain Stimulator

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Dual Channel Deep Brain Stimulator

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY TARGET

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Target

    • 5.2. Thalamus

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Subthalamic Nucleus

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Globus Pallidus

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Pedunculopontine Nucleus

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Chronic Pain

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Dystonia

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Alzheimer's Disease

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Depression

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Obsessive Compulsive Disorder

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Epilepsy

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

    • 6.8. Parkinsons Disease

      • 6.8.1. Key Market Trends, Growth Factors and Opportunities

      • 6.8.2. Market Size and Forecast, By Region

      • 6.8.3. Market Share Analysis, By Country

    • 6.9. Others

      • 6.9.1. Key Market Trends, Growth Factors and Opportunities

      • 6.9.2. Market Size and Forecast, By Region

      • 6.9.3. Market Share Analysis, By Country

  • CHAPTER 7: NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Target

      • 7.2.4. Market Size and Forecast, By Application

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S.

        • 7.2.6.1 Market size and forecast, product

        • 7.2.6.2 Market size and forecast, target

        • 7.2.6.3 Market size and forecast, application

      • 7.2.7. Canada

        • 7.2.7.1 Market size and forecast, product

        • 7.2.7.2 Market size and forecast, target

        • 7.2.7.3 Market size and forecast, application

      • 7.2.8. Mexico

        • 7.2.8.1 Market size and forecast, product

        • 7.2.8.2 Market size and forecast, target

        • 7.2.8.3 Market size and forecast, application

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Target

      • 7.3.4. Market Size and Forecast, By Application

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France

        • 7.3.6.1 Market size and forecast, product

        • 7.3.6.2 Market size and forecast, target

        • 7.3.6.3 Market size and forecast, application

      • 7.3.7. Germany

        • 7.3.7.1 Market size and forecast, product

        • 7.3.7.2 Market size and forecast, target

        • 7.3.7.3 Market size and forecast, application

      • 7.3.8. Italy

        • 7.3.8.1 Market size and forecast, product

        • 7.3.8.2 Market size and forecast, target

        • 7.3.8.3 Market size and forecast, application

      • 7.3.9. Spain

        • 7.3.9.1 Market size and forecast, product

        • 7.3.9.2 Market size and forecast, target

        • 7.3.9.3 Market size and forecast, application

      • 7.3.10. UK

        • 7.3.10.1 Market size and forecast, product

        • 7.3.10.2 Market size and forecast, target

        • 7.3.10.3 Market size and forecast, application

      • 7.3.11. Russia

        • 7.3.11.1 Market size and forecast, product

        • 7.3.11.2 Market size and forecast, target

        • 7.3.11.3 Market size and forecast, application

      • 7.3.12. Rest Of Europe

        • 7.3.12.1 Market size and forecast, product

        • 7.3.12.2 Market size and forecast, target

        • 7.3.12.3 Market size and forecast, application

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Target

      • 7.4.4. Market Size and Forecast, By Application

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China

        • 7.4.6.1 Market size and forecast, product

        • 7.4.6.2 Market size and forecast, target

        • 7.4.6.3 Market size and forecast, application

      • 7.4.7. Japan

        • 7.4.7.1 Market size and forecast, product

        • 7.4.7.2 Market size and forecast, target

        • 7.4.7.3 Market size and forecast, application

      • 7.4.8. India

        • 7.4.8.1 Market size and forecast, product

        • 7.4.8.2 Market size and forecast, target

        • 7.4.8.3 Market size and forecast, application

      • 7.4.9. South Korea

        • 7.4.9.1 Market size and forecast, product

        • 7.4.9.2 Market size and forecast, target

        • 7.4.9.3 Market size and forecast, application

      • 7.4.10. Australia

        • 7.4.10.1 Market size and forecast, product

        • 7.4.10.2 Market size and forecast, target

        • 7.4.10.3 Market size and forecast, application

      • 7.4.11. Thailand

        • 7.4.11.1 Market size and forecast, product

        • 7.4.11.2 Market size and forecast, target

        • 7.4.11.3 Market size and forecast, application

      • 7.4.12. Malaysia

        • 7.4.12.1 Market size and forecast, product

        • 7.4.12.2 Market size and forecast, target

        • 7.4.12.3 Market size and forecast, application

      • 7.4.13. Indonesia

        • 7.4.13.1 Market size and forecast, product

        • 7.4.13.2 Market size and forecast, target

        • 7.4.13.3 Market size and forecast, application

      • 7.4.14. Rest of Asia Pacific

        • 7.4.14.1 Market size and forecast, product

        • 7.4.14.2 Market size and forecast, target

        • 7.4.14.3 Market size and forecast, application

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Target

      • 7.5.4. Market Size and Forecast, By Application

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil

        • 7.5.6.1 Market size and forecast, product

        • 7.5.6.2 Market size and forecast, target

        • 7.5.6.3 Market size and forecast, application

      • 7.5.7. South Africa

        • 7.5.7.1 Market size and forecast, product

        • 7.5.7.2 Market size and forecast, target

        • 7.5.7.3 Market size and forecast, application

      • 7.5.8. Saudi Arabia

        • 7.5.8.1 Market size and forecast, product

        • 7.5.8.2 Market size and forecast, target

        • 7.5.8.3 Market size and forecast, application

      • 7.5.9. UAE

        • 7.5.9.1 Market size and forecast, product

        • 7.5.9.2 Market size and forecast, target

        • 7.5.9.3 Market size and forecast, application

      • 7.5.10. Argentina

        • 7.5.10.1 Market size and forecast, product

        • 7.5.10.2 Market size and forecast, target

        • 7.5.10.3 Market size and forecast, application

      • 7.5.11. Rest of LAMEA

        • 7.5.11.1 Market size and forecast, product

        • 7.5.11.2 Market size and forecast, target

        • 7.5.11.3 Market size and forecast, application

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Medtronic Plc,

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Boston Scientific Corporation,

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Enteromedics,

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Cyberonics,

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. St. Jude Medical, Inc.,

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Neuropace,

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Zynex,

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Neuronetics,

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Functional Neuromodulation Ltd.,

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Neurosigma, Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR SINGLE CHANNEL DEEP BRAIN STIMULATOR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR DUAL CHANNEL DEEP BRAIN STIMULATOR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 5. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR THALAMUS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR SUBTHALAMIC NUCLEUS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR GLOBUS PALLIDUS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR PEDUNCULOPONTINE NUCLEUS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR CHRONIC PAIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR DYSTONIA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR ALZHEIMER'S DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR DEPRESSION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR EPILEPSY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR PARKINSONS DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 23. U.S. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. U.S. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 25. U.S. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. CANADA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. CANADA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 28. CANADA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. ITALY NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. ITALY NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 44. ITALY NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. UK NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. UK NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 50. UK NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. RUSSIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 53. RUSSIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. REST OF EUROPE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 56. REST OF EUROPE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 59. ASIA-PACIFIC NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. ASIA-PACIFIC NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 61. CHINA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. CHINA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 63. CHINA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. JAPAN NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 66. JAPAN NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. INDIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. INDIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 69. INDIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 72. SOUTH KOREA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. AUSTRALIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 75. AUSTRALIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. THAILAND NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 78. THAILAND NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. MALAYSIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 81. MALAYSIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 83. INDONESIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 84. INDONESIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 87. REST OF ASIA PACIFIC NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 90. LAMEA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. LAMEA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. BRAZIL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 94. BRAZIL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 97. SOUTH AFRICA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 99. SAUDI ARABIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 100. SAUDI ARABIA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. UAE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. UAE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 103. UAE NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. ARGENTINA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 106. ARGENTINA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 108. REST OF LAMEA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY TARGET, 2022-2032 ($MILLION)
  • TABLE 109. REST OF LAMEA NORTH AMERICA DEEP BRAIN STIMULATION DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 110. MEDTRONIC PLC,: KEY EXECUTIVES
  • TABLE 111. MEDTRONIC PLC,: COMPANY SNAPSHOT
  • TABLE 112. MEDTRONIC PLC,: OPERATING SEGMENTS
  • TABLE 113. MEDTRONIC PLC,: PRODUCT PORTFOLIO
  • TABLE 114. MEDTRONIC PLC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. BOSTON SCIENTIFIC CORPORATION,: KEY EXECUTIVES
  • TABLE 116. BOSTON SCIENTIFIC CORPORATION,: COMPANY SNAPSHOT
  • TABLE 117. BOSTON SCIENTIFIC CORPORATION,: OPERATING SEGMENTS
  • TABLE 118. BOSTON SCIENTIFIC CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 119. BOSTON SCIENTIFIC CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. ENTEROMEDICS,: KEY EXECUTIVES
  • TABLE 121. ENTEROMEDICS,: COMPANY SNAPSHOT
  • TABLE 122. ENTEROMEDICS,: OPERATING SEGMENTS
  • TABLE 123. ENTEROMEDICS,: PRODUCT PORTFOLIO
  • TABLE 124. ENTEROMEDICS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. CYBERONICS,: KEY EXECUTIVES
  • TABLE 126. CYBERONICS,: COMPANY SNAPSHOT
  • TABLE 127. CYBERONICS,: OPERATING SEGMENTS
  • TABLE 128. CYBERONICS,: PRODUCT PORTFOLIO
  • TABLE 129. CYBERONICS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. ST. JUDE MEDICAL, INC.,: KEY EXECUTIVES
  • TABLE 131. ST. JUDE MEDICAL, INC.,: COMPANY SNAPSHOT
  • TABLE 132. ST. JUDE MEDICAL, INC.,: OPERATING SEGMENTS
  • TABLE 133. ST. JUDE MEDICAL, INC.,: PRODUCT PORTFOLIO
  • TABLE 134. ST. JUDE MEDICAL, INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. NEUROPACE,: KEY EXECUTIVES
  • TABLE 136. NEUROPACE,: COMPANY SNAPSHOT
  • TABLE 137. NEUROPACE,: OPERATING SEGMENTS
  • TABLE 138. NEUROPACE,: PRODUCT PORTFOLIO
  • TABLE 139. NEUROPACE,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. ZYNEX,: KEY EXECUTIVES
  • TABLE 141. ZYNEX,: COMPANY SNAPSHOT
  • TABLE 142. ZYNEX,: OPERATING SEGMENTS
  • TABLE 143. ZYNEX,: PRODUCT PORTFOLIO
  • TABLE 144. ZYNEX,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. NEURONETICS,: KEY EXECUTIVES
  • TABLE 146. NEURONETICS,: COMPANY SNAPSHOT
  • TABLE 147. NEURONETICS,: OPERATING SEGMENTS
  • TABLE 148. NEURONETICS,: PRODUCT PORTFOLIO
  • TABLE 149. NEURONETICS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. FUNCTIONAL NEUROMODULATION LTD.,: KEY EXECUTIVES
  • TABLE 151. FUNCTIONAL NEUROMODULATION LTD.,: COMPANY SNAPSHOT
  • TABLE 152. FUNCTIONAL NEUROMODULATION LTD.,: OPERATING SEGMENTS
  • TABLE 153. FUNCTIONAL NEUROMODULATION LTD.,: PRODUCT PORTFOLIO
  • TABLE 154. FUNCTIONAL NEUROMODULATION LTD.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 155. NEUROSIGMA, INC.: KEY EXECUTIVES
  • TABLE 156. NEUROSIGMA, INC.: COMPANY SNAPSHOT
  • TABLE 157. NEUROSIGMA, INC.: OPERATING SEGMENTS
  • TABLE 158. NEUROSIGMA, INC.: PRODUCT PORTFOLIO
  • TABLE 159. NEUROSIGMA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET
  • FIGURE 3. SEGMENTATION NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET
  • FIGURE 11. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 12. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR SINGLE CHANNEL DEEP BRAIN STIMULATOR, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR DUAL CHANNEL DEEP BRAIN STIMULATOR, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SEGMENTATION, BY TARGET
  • FIGURE 15. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR THALAMUS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR SUBTHALAMIC NUCLEUS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR GLOBUS PALLIDUS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR PEDUNCULOPONTINE NUCLEUS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 20. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR CHRONIC PAIN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR DYSTONIA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR ALZHEIMER'S DISEASE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR DEPRESSION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR PARKINSONS DISEASE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET
  • FIGURE 34. TOP PLAYER POSITIONING,2022
  • FIGURE 35. MEDTRONIC PLC,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. MEDTRONIC PLC,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. MEDTRONIC PLC,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. BOSTON SCIENTIFIC CORPORATION,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. BOSTON SCIENTIFIC CORPORATION,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. BOSTON SCIENTIFIC CORPORATION,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. ENTEROMEDICS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. ENTEROMEDICS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. ENTEROMEDICS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. CYBERONICS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. CYBERONICS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. CYBERONICS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. ST. JUDE MEDICAL, INC.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. ST. JUDE MEDICAL, INC.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. ST. JUDE MEDICAL, INC.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. NEUROPACE,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. NEUROPACE,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. NEUROPACE,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. ZYNEX,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. ZYNEX,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. ZYNEX,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. NEURONETICS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. NEURONETICS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. NEURONETICS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. FUNCTIONAL NEUROMODULATION LTD.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. FUNCTIONAL NEUROMODULATION LTD.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. FUNCTIONAL NEUROMODULATION LTD.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. NEUROSIGMA, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. NEUROSIGMA, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. NEUROSIGMA, INC.: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
North America Deep Brain Stimulation Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved